000 03501nam a22005295i 4500
001 978-3-642-00477-3
003 DE-He213
005 20140220084521.0
007 cr nn 008mamaa
008 100316s2010 gw | s |||| 0|eng d
020 _a9783642004773
_9978-3-642-00477-3
024 7 _a10.1007/978-3-642-00477-3
_2doi
050 4 _aRM1-950
072 7 _aMMG
_2bicssc
072 7 _aMED071000
_2bisacsh
082 0 4 _a615
_223
100 1 _aSchäfer-Korting, Monika.
_eeditor.
245 1 0 _aDrug Delivery
_h[electronic resource] /
_cedited by Monika Schäfer-Korting.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2010.
300 _aXIV, 501 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aHandbook of Experimental Pharmacology,
_x0171-2004 ;
_v197
505 0 _aFundamentals -- Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example -- Nanoparticle Technologies for Cancer Therapy -- Biosensing and Drug Delivery at the Microscale -- Devices -- Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes -- Viral Vectors for Gene Transfer: Current Status of Gene Therapeutics -- Pulmonary Drug Delivery: Medicines for Inhalation -- Needle-Free Vaccine Injection -- Pharmaceutically Used Polymers: Principles, Structures, and Applications of Pharmaceutical Delivery Systems -- Mucoadhesive Drug Delivery Systems -- Intrauterine Drug Delivery for Contraception and Gynaecological Treatment: Novel Approaches -- Drug-Eluting Medical Implants -- Clinical and Preclinical Application of Therapeutics for Systemic Use -- Improving Oral Delivery -- Transdermal Drug Delivery -- Targeting the Brain – Surmounting or Bypassing the Blood–Brain Barrier -- Clinical and Preclinical Application of Therapeutics for Topical Use -- Carriers in the Topical Treatment of Skin Disease -- Medical Devices for the Treatment of Eye Diseases -- Erratum to: Biosensing and Drug Delivery at the Microscale.
520 _aIn the view of most experts pharmacology is on drugs, targets, and actions. In the context the drug as a rule is seen as an active pharmaceutical ingredient and not as a complex mixture of chemical entities of a well defined structure. Today, we are becoming more and more aware of the fact that delivery of the active compound to the target site is a key. The present volume gives a topical overview on various modern approaches to drug targeting covering today’s options for specific carrier systems allowing successful drug treatment at various sites of the body difficult to address and allowing to increase the benefit-risk-ratio to the optimum possible.
650 0 _aMedicine.
650 0 _aToxicology.
650 0 _aPharmaceutical technology.
650 0 _aDermatology.
650 0 _aNeurology.
650 0 _aOncology.
650 1 4 _aBiomedicine.
650 2 4 _aPharmacology/Toxicology.
650 2 4 _aPharmaceutical Sciences/Technology.
650 2 4 _aOncology.
650 2 4 _aDermatology.
650 2 4 _aNeurology.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783642004766
830 0 _aHandbook of Experimental Pharmacology,
_x0171-2004 ;
_v197
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-00477-3
912 _aZDB-2-SBL
999 _c111313
_d111313